Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biote Corp (BTMD)

Biote Corp (BTMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 52,207
  • Shares Outstanding, K 39,551
  • Annual Sales, $ 192,220 K
  • Annual Income, $ 27,050 K
  • EBIT $ 36 M
  • EBITDA $ 40 M
  • 60-Month Beta 1.14
  • Price/Sales 0.28
  • Price/Cash Flow 2.33
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.09
  • Number of Estimates 1
  • High Estimate 0.09
  • Low Estimate 0.09
  • Prior Year 0.08
  • Growth Rate Est. (year over year) +12.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2700 +2.36%
on 03/30/26
2.1800 -40.37%
on 03/03/26
-0.8200 (-38.68%)
since 02/27/26
3-Month
1.2700 +2.36%
on 03/30/26
2.7400 -52.55%
on 12/29/25
-1.3800 (-51.49%)
since 12/26/25
52-Week
1.2700 +2.36%
on 03/30/26
4.7498 -72.63%
on 07/29/25
-2.0900 (-61.65%)
since 03/28/25

Most Recent Stories

More News
Biote Reports Fourth Quarter and Full Year 2025 Financial Results

Executing efficiently on strategic priorities Continued salesforce expansion to capture large growth opportunity Anticipate a return...

BTMD : 1.3000 (-1.52%)
Should Risk-Takers Roll the Dice on These 3 Penny Stocks at 52-Week Lows?

The Iran war has reduced the number of new 52-week highs on the NYSE and Nasdaq, and new 52-week lows now dominate across both exchanges. Among the 157 stocks hitting new 52-week lows, three penny stocks...

KLC : 2.13 (+3.90%)
$SPX : 6,343.72 (-0.39%)
BTMD : 1.3000 (-1.52%)
AIV : 3.98 (+0.76%)
Biote Schedules Fourth Quarter and Full Year 2025 Financial Results Release and Conference Call

biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading innovator advancing the healthspan of patients’ lives by providing hormone replacement therapy and healthy aging solutions, today...

BTMD : 1.3000 (-1.52%)
Biote Reports Third Quarter 2025 Financial Results

Continued progress against strategic priorities Repurchased approximately one million shares of Class A common stock Reiterates 2025...

BTMD : 1.3000 (-1.52%)
Biote Schedules Third Quarter 2025 Financial Results Release and Conference Call

biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness,...

BTMD : 1.3000 (-1.52%)
Biote Reports Second Quarter 2025 Financial Results

Q2 financial performance driven by strong dietary supplement sales and gross margin expansion Launched corporate reorganization to increase...

BTMD : 1.3000 (-1.52%)
Biote Schedules Second Quarter 2025 Financial Results Release and Conference Call

biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness,...

BTMD : 1.3000 (-1.52%)
Biote Schedules First Quarter 2023 Financial Results Release and Conference Call

biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading provider of preventive health care through the delivery of personalized hormone therapy, today announced the Company will provide...

BTMD : 1.3000 (-1.52%)
Biote Names John Denne as General Manager, Men’s Health Division

Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today announced that John Denne has joined the Company as General Manager,...

BTMD : 1.3000 (-1.52%)
Biote Reports Fourth Quarter and Full Year 2022 Financial Results

Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today announced financial results for the fourth quarter and full year...

BTMD : 1.3000 (-1.52%)

Business Summary

BioTE Holdings, LLC is a medical practice-building business within the hormone optimization space. BioTE Holdings, LLC, formerly known as Haymaker Acquisition Corp. III, is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 1.4400
2nd Resistance Point 1.4000
1st Resistance Point 1.3500
Last Price 1.3000
1st Support Level 1.2600
2nd Support Level 1.2200
3rd Support Level 1.1700

See More

52-Week High 4.7498
Fibonacci 61.8% 3.4205
Fibonacci 50% 3.0099
Fibonacci 38.2% 2.5993
Last Price 1.3000
52-Week Low 1.2700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.